CV

Cogene Ventures

North America, Texas, United States, Houston

Description

Cogene Ventures, a Texas-based venture capital firm, specializes in early-, mid-, expansion-, and late-stage investments.

Investor Profile

Cogene Ventures has made 8 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (25%)
  • Series Unknown (25%)
  • Series B (25%)
  • Series D (25%)

Country Focus

  • United States (75%)
  • Canada (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Therapeutics
  • Manufacturing
  • Medical
  • Life Science
  • Developer Platform
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cogene Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 3
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 2
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 4
DC
North America, Wisconsin, United States, Pewaukee
Co-Investments: 1
HV
North America, New York, United States, New York
Co-Investments: 2
BDC Venture Capital
North America, Alberta, Canada, Calgary
Co-Investments: 2
GrowthWorks Capital
North America, British Columbia, Canada, Vancouver
Co-Investments: 2
RBC Capital
North America, Ontario, Canada, Toronto
Co-Investments: 2
Aperture Venture Partners
North America, New York, United States, New York
Co-Investments: 1
MDS Capital
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by Cogene Ventures?

Neuromed Pharmaceuticals

Vancouver, British Columbia, Canada

Neuromed Pharmaceuticals, Ltd., a biopharmaceutical company, develops, produces, markets, and sells pain therapies.

BiopharmaBiotechnologyHealth Care
Series DMar 8, 2006
Amount Raised: $25,000,000
Raven Biotechnologies

South San Francisco, California, United States

Raven biotechnologies is focused on the development of monoclonal antibody therapeutics for the treatment of cancer.

BiotechnologyMedicalTherapeutics
Series DOct 24, 2005
Amount Raised: $48,300,000
MacroGenics

Rockville, Maryland, United States

MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.

BiotechnologyHealth CareManufacturing
Series BOct 15, 2004
Amount Raised: $30,500,000
Rejuvenon

The Woodlands, Texas, United States

Rejuvenon a biopharmaceutical company committed developing and commercializing promising compounds for treatment of oncologic diseases.

BiotechnologyDeveloper PlatformMedical
Series BJun 23, 2004
Amount Raised: $37,000,000
TransMolecular

Birmingham, Alabama, United States

TransMolecular Inc a Birmingham, Ala.-based biotech company focused on the treatment of cancer and pain.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CMar 1, 2004
Amount Raised: $33,200,000
Neuromed Pharmaceuticals

Vancouver, British Columbia, Canada

Neuromed Pharmaceuticals, Ltd., a biopharmaceutical company, develops, produces, markets, and sells pain therapies.

BiopharmaBiotechnologyHealth Care
Series CNov 4, 2003
Amount Raised: $32,000,000
Catalyst Biosciences

South San Francisco, California, United States

Catalyst Biosciences is a biopharmaceutical company that offers protease therapeutics to address disorders of the coagulation system.

BiopharmaBiotechnologyLife SciencePharmaceutical
Series UnknownMar 20, 2003
Amount Raised: $60,000,000
MacroGenics

Rockville, Maryland, United States

MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.

BiotechnologyHealth CareManufacturing
Series UnknownJun 7, 2002
Amount Raised: $12,600,000